Letter to the Editor

Letter to the Editor

Valproate Prescribing in Individuals of Childbearing Age

October 12, 2022

Camille Tastenhoye, MD, and colleagues share data from a tertiary care women’s hospital that highlight opportunities for improvement in valproate prescribing practices.

Letter to the Editor

Addressing the Problem of Prescription of Valproate to Women of Childbearing Age: Reply to Tastenhoye et al

October 12, 2022

Chittaranjan Andrade, MD, responds to a letter by Tastenhoye et al and comments on his recent study on valproate prescription in women.

Letter to the Editor

Asenapine, Aggression, and Affinity

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.

Letter to the Editor

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.

Letter to the Editor

Mental Well-Being of Health Care Workers During the COVID-19 Pandemic

July 19, 2022

Here, the authors discuss the psychological impact of working during the pandemic on health care workers in Northern Italy.

Letter to the Editor

Mindfulness Training in Opioid Withdrawal

June 30, 2022

In this letter to the editor, the authors comment on an article published recently in the PCC.